Developing trends in bioanalysis

Bioanalysis

Volumn 1, Issue 8, 2009, Pages 1359-1364

  Hill, Howard ^a  

^a Pharmaceutical Analytical Services   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

BLOOD ANALYSIS; CALIBRATION; CHEMICAL ANALYSIS; CONFERENCE PAPER; FOOD AND DRUG ADMINISTRATION; HUMAN; INSTRUMENTATION; LEGAL ASPECT; METHODOLOGY; UNITED STATES;

BLOOD CHEMICAL ANALYSIS; CALIBRATION; CHEMISTRY TECHNIQUES, ANALYTICAL; HUMANS; PHARMACEUTICAL PREPARATIONS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77954712948     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/BIO.09.129     Document Type: Conference Paper

References (10)

1. US FDA. Guidance for Industry; Bioanalytical Method Validation. Center for Drug Evaluation and Research, 5600 Fishers Lane, Rockville, MD 20857, USA (2001).
2. European Medicines Agency. Concept Paper/recommendation on the Need for a (CHMP) Guideline on the Validation of Bioanalytical Methods. Released 18 December 2008 for comment. European Medicines Agency. Document Reference EMEA/CHMP/EWP/531305/2008 (2008).
3. Vishwanathan CT, Bansal S, Booth B et al. Quantitative bionalytical methods validation and implementation; best practices for chromatographic and ligand binding assays. Pharm. Res. 4(10), 1962-1973 (2007).
4. Fast DM, Kelley M, Vishawanathan CT et al. Workshop report and follow-up - AAPS workshop on current topics in GLP bioanalysis assay reproducibility for incurred samples: implication of Crystal City recommendation. AAPS J. 11(2) 238-241 (2009).
5. US FDA. Guidance for Industry, Safety Testing of Drug Metabolites. FDA, Rockville, MD 20857, USA (2008).
6. Baillie TA, Cayen MN, Fouda H et al. Drug metabolites in safety testing. Toxicol. Appl. Pharm. 182(3), 188-196 (2002).
7. Smith DA, Obach RS. Seeing through the MIST: abundance versus percentage. Commentary on metabolites in safety testing. Drug Metab. Disp. 33(10), 1409-1417 (2005).
8. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in a large population of new born infants. Pediatrics 32, 338-343 (1963).
9. Houghton R, Horro Pita C, Ward I, Macarthur R. Generic approach to validation of small molecule LC-MS/MS biomarker assays. Bioanalysis 1(8), 1365-1374 (2009).
10. Ezan E. Critical comparison of mass spectrometry and immunoassays for the bioanalysis of therapeutic antibodies. Bioanalysis 1(8), 1375-1388 (2009).